These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28274562)

  • 1. Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503.
    Kohman LJ; Gu L; Altorki N; Scalzetti E; Veit LJ; Wallen JM; Wang X
    J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1592-1597. PubMed ID: 28274562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
    AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
    [No Abstract]   [Full Text] [Related]  

  • 4. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?
    Kozower BD; Meyers BF; Reed CE; Jones DR; Decker PA; Putnam JB
    Ann Thorac Surg; 2008 Apr; 85(4):1166-9; discussion 1169-70. PubMed ID: 18355490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).
    Altorki NK; Wang X; Wigle D; Gu L; Darling G; Ashrafi AS; Landrenau R; Miller D; Liberman M; Jones DR; Keenan R; Conti M; Wright G; Veit LJ; Ramalingam SS; Kamel M; Pass HI; Mitchell JD; Stinchcombe T; Vokes E; Kohman LJ
    Lancet Respir Med; 2018 Dec; 6(12):915-924. PubMed ID: 30442588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
    D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA;
    Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.
    Altorki N; Wang X; Kozono D; Watt C; Landrenau R; Wigle D; Port J; Jones DR; Conti M; Ashrafi AS; Liberman M; Yasufuku K; Yang S; Mitchell JD; Pass H; Keenan R; Bauer T; Miller D; Kohman LJ; Stinchcombe TE; Vokes E
    N Engl J Med; 2023 Feb; 388(6):489-498. PubMed ID: 36780674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions.
    Rzyman W; Jelitto-Gorska M; Dziedzic R; Biadacz I; Ksiazek J; Chwirot P; Marjanski T
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):969-73. PubMed ID: 24008181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers.
    Wolf AS; Richards WG; Jaklitsch MT; Gill R; Chirieac LR; Colson YL; Mohiuddin K; Mentzer SJ; Bueno R; Sugarbaker DJ; Swanson SJ
    Ann Thorac Surg; 2011 Nov; 92(5):1819-23; discussion 1824-5. PubMed ID: 22051277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
    Moon Y; Lee KY; Park JK
    World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial.
    Yang F; Sui X; Chen X; Zhang L; Wang X; Wang S; Wang J
    Trials; 2016 Apr; 17():191. PubMed ID: 27053091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.
    Yang CF; Adil SM; Anderson KL; Meyerhoff RR; Turley RS; Hartwig MG; Harpole DH; Tong BC; Onaitis MW; D'Amico TA; Berry MF
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1607-13. PubMed ID: 26719403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
    Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
    Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoracoscopic segmentectomy with intraoperative evaluation of sentinel nodes for stage I non-small cell lung cancer.
    Moroga T; Yamashita S; Tokuishi K; Miyawaki M; Anami K; Yamamoto S; Kawahara K
    Ann Thorac Cardiovasc Surg; 2012; 18(2):89-94. PubMed ID: 22082811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Occult Peribronchial N1 Nodal Metastasis in Peripheral Clinical N0 Small (≤2 cm) Non-Small Cell Lung Cancer.
    Robinson EM; Ilonen IK; Tan KS; Plodkowski AJ; Bott M; Bains MS; Adusumilli PS; Park BJ; Rusch VW; Jones DR; Huang J
    Ann Thorac Surg; 2020 Jan; 109(1):270-276. PubMed ID: 31479639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system).
    Stamatis G; Leschber G; Schwarz B; Brintrup DL; Ose C; Weinreich G; Passlick B; Hecker E; Kugler C; Dienemann H; Krbek T; Eggeling S; Hatz R; Müller MR; Weder W; Aigner C; Jöckel KH
    Lung Cancer; 2019 Dec; 138():19-26. PubMed ID: 31606521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.